Intuitive Surgical
Prezzo: 411.06Società e modello di business
Intuitive Surgical is a leader in robotic-assisted surgical systems, primarily known for its da Vinci Surgical System. The company develops and markets advanced surgical technologies, including instruments and accessories that enhance minimally invasive surgery. Its core revenue sources stem from system sales, instrument and accessory sales, and service agreements. The company operates mainly in the healthcare sector, focusing on improving surgical outcomes and patient recovery times.
Profilo di investimento
Intuitive Surgical's stock is more aligned with growth investors due to its focus on innovation and expanding market presence in robotic surgery. The absence of dividends and the current volatility suggest a higher risk profile, making it less suitable for conservative investors. The company is positioned for potential long-term growth, appealing to those willing to accept higher risk for future returns.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 8.37 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- -3.3% ↓
- Sorpresa EPS
- 17.9% meglio del previsto
- Volatilità 20g
- 2.5% stabile
Impatto della previsione
negativoTraccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-05-24 02:42 | Mantieni | Vendi | Weak momentum and fundamentals suggest caution. |
| 2026-05-16 02:32 | Vendi | Mantieni | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-08 14:59 | — | Vendi | Weak momentum and fundamentals raise significant risk concerns. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-06-02 12:24 | Piper Sandler | Aggiorna | — → 580 | 397.60999 |
| 2026-05-27 11:27 | Goldman Sachs | Target abbassato | 621 → 558 | 436.64 |
| 2026-04-23 10:18 | Barclays | Target abbassato | 712 → 651 | 483.62 |
Ancora nulla